| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11019022 | Heart, Lung and Circulation | 2018 | 8 Pages |
Abstract
The epidemiology and survival of patients with idiopathic PAH in Australia and New Zealand are similar to contemporary registries reported in Europe and North America. Male sex and poorer exercise capacity are predictive of mortality whereas obesity appears to exert a protective effect. Despite current therapies, PAH remains a life-threatening disease associated with significant early mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Geoff PhD, Edmund M. MBBS, PhD, Eleni PhD, Carolyn BN, Eugene BBS, MD, Fiona MBBS, Trevor MBBS, MD, David S. MBBS, PhD, Nathan MBBS, PhD, Helen MBBS, MD, Jeremy P. MBBS, PhD, John MBBS, Melanie MBBS, Kenneth MBBS, Nicholas MBBS, Peter MBBS, Susanna MBBS,